Treatment-related mortality (TRM) was defined as non-relapse death within 100 days from transplantation. Overall and progression free survival (OS, PFS) were defined from the time of stem cell ...
At the Second International Conference on Cell Therapy for Cardiovascular Diseases, held January 19-21, 2006, in New York, NY, interim data from 3 ongoing trials of bone marrow-derived cells (BMCs) -- ...
* Acquired Tecam with part of purchase price deferred over a two-year period contingent on business achieving certain financial hurdles Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results